Contents
Breakthrough Research: New Insights into Barrett's Esophagus Detection
Published: Dec 31, 2023
Exciting new research is changing how we detect and understand Barrett's esophagus. These studies could lead to easier, more accurate diagnosis and better patient outcomes.
The Cytosponge Revolution
A groundbreaking study has introduced a new, non-invasive method for detecting Barrett's esophagus: the Cytosponge. This device, about the size of a multivitamin, is swallowed and then retrieved, collecting cells from the esophagus along the way. These cells are then tested for signs of Barrett's esophagus. In a large trial, the Cytosponge identified ten times more cases of Barrett's esophagus than usual care. It's like fishing for abnormal cells, but with a tiny sponge instead of a hook!
Biomarkers: The Future of Diagnosis?
Researchers are exploring the use of biomarkers to detect Barrett's esophagus more accurately. One study found that a protein called trefoil factor 3 (TFF3) is a promising marker for Barrett's cells. When combined with the Cytosponge, TFF3 testing showed high accuracy in identifying Barrett's esophagus. It's like having a specific 'tag' that only attaches to Barrett's cells, making them easier to spot.
Genetics and Barrett's Esophagus
Genetic studies are shedding light on why some people develop Barrett's esophagus. Researchers have identified several genes that may increase susceptibility to Barrett's, including MSR1, ASCC1, and CTHRC1. Another study found genetic variants associated with Barrett's at chromosomes 6p21 and 16q24. It's like uncovering the genetic 'recipe' that might predispose someone to Barrett's esophagus.
Frequently Asked Questions
It's highly accurate for Barrett's segments 2cm or longer.
Not yet, but research is progressing rapidly.
They may reduce need for endoscopy, but can't fully replace it yet.
Some, like Cytosponge, are in clinical trials now.
A Brighter Future
These research breakthroughs offer hope for easier, more accurate detection of Barrett's esophagus, potentially saving lives through earlier diagnosis.
References
- Fitzgerald RC, di Pietro M, O'Donovan M, et al. Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial. Lancet 2020; 396:333.
- Kadri SR, Lao-Sirieix P, O'Donovan M, et al. Acceptability and accuracy of a non-endoscopic screening test for Barrett's oesophagus in primary care: cohort study. BMJ 2010; 341:c4372.
- Orloff M, Peterson C, He X, et al. Germline mutations in MSR1, ASCC1, and CTHRC1 in patients with Barrett esophagus and esophageal adenocarcinoma. JAMA 2011; 306:410.
- Su Z, Gay LJ, Strange A, et al. Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus. Nat Genet 2012; 44:1131.
This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic. Always discuss health information with your healthcare provider.
AI Doctor Visit Required
Appointments available 24/7
Top licensed doctors
Available in all 50 states
Full service care
Prescriptions, referrals & treatment
No insurance needed
All notes available in Doctronic
15-min consultation. No hidden costs.
AI Doctor Visit Required
Please Chat With Our AI Doctor First
Our AI doctor assessment helps our human doctors prepare for your video visit and provide better care
For safety reasons we have been forced to end this consultation.
If you believe this is a medical emergency please call 911 or your local emergency services immediately.
If you are experiencing emotional distress, please call the the Suicide & Crisis Lifeline at 988 or your local crisis services immediately.
Contact us
You can also email us at help@doctronic.ai
We aim to reply within 5-7 days
How likely are you to recommend Doctronic to friends or family?